Active, not recruitingPhase 4NCT05003648
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Studying Peroxisomal acyl-CoA oxidase deficiency
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Massachusetts General Hospital
- Principal Investigator
- Florian S Eichler, MDMassachusetts General Hospital
- Intervention
- Pramipexole(drug)
- Enrollment
- 24 enrolled
- Eligibility
- 18-75 years · FEMALE
- Timeline
- 2023 – 2025
Study locations (2)
- Massachusetts General Hospital, Boston, Massachusetts, United States
- University Medical Center of Amsterdam, Amsterdam, Netherlands
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05003648 on ClinicalTrials.govOther trials for Peroxisomal acyl-CoA oxidase deficiency
Additional recruiting or active studies for the same condition.
See all trials for Peroxisomal acyl-CoA oxidase deficiency →